Dual-acting PPARgamma/PPARalpha agonist NNC-61-0029/(-)-DRF-2725: pharmacology and clinical PK July 2, 2001
Antisense oligonucleotide targeting PTP1B effective in animal models of diabetes, insulin resistance July 2, 2001
ADA news: SGLT inhibitor RWJ-394718 has favorable effects in rodent models of type 2 diabetes June 29, 2001
AZ-242, a novel PPARalpha/PPARgamma activator for insulin resistance syndrome, type 2 diabetes June 29, 2001
RSS